Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |